Will Spotify Smash Its All-Time High of $387?

Music streamer Spotify Technology (SPOT) isn’t a cheap stock. But it might not be considered overvalued either, despite its earnings having been rather “spotty” (pardon the pun) and dipping into negative territory before last October. Spotify’s performance has been remarkable over the past 16 months, with a consistent upward trajectory and a 98.4 SCTR score….

Read More

Should Risk Averse Traders Buy Penny Stocks?

3 Reasons Why Risk Averse Investors Could Trade Penny Stocks Penny stocks often attract investors looking for substantial returns on small initial investments. Despite their reputation for high volatility, there are compelling reasons why even risk-averse traders might consider adding them to their portfolios. Firstly, the potential for rapid growth can be significantly higher with…

Read More

Penny Stock Trading Psychology: Mastering Emotional Discipline

3 Tips for Making Money With Penny Stocks Through Emotional Discipline Penny stocks represent a unique opportunity for investors seeking significant gains with a modest initial investment. Trading penny stocks effectively requires more than just market knowledge; it demands a high level of emotional discipline to navigate the rapid price fluctuations that characterize these investments….

Read More

Aurora Cannabis Inc. (ACB) Unveils Premium Resin Cartridges in Australia

Aurora Unveils Premium Resin Cartridges in Australia Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is excited to announce the launch of its premium 1.2g resin cartridges in Australia. This expansion marks a significant step in Aurora’s mission to provide high-quality products…

Read More

BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., April 24, 2024 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE). Class Period: April 24, 2023 – December 8, 2023Lead Plaintiff Deadline: May 28, 2024 Investors suffering losses…

Read More